TRUP vs. OSCR, WABC, HOPE, NTST, MMI, FBNC, CNNE, LMND, NMFC, and NBHC
Should you be buying Trupanion stock or one of its competitors? The main competitors of Trupanion include Oscar Health (OSCR), Westamerica Bancorporation (WABC), Hope Bancorp (HOPE), NETSTREIT (NTST), Marcus & Millichap (MMI), First Bancorp (FBNC), Cannae (CNNE), Lemonade (LMND), New Mountain Finance (NMFC), and National Bank (NBHC). These companies are all part of the "finance" sector.
Trupanion (NASDAQ:TRUP) and Oscar Health (NYSE:OSCR) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and community ranking.
Oscar Health has a net margin of -0.82% compared to Trupanion's net margin of -2.31%. Oscar Health's return on equity of -5.77% beat Trupanion's return on equity.
Trupanion has higher earnings, but lower revenue than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Trupanion, indicating that it is currently the more affordable of the two stocks.
75.7% of Oscar Health shares are held by institutional investors. 5.8% of Trupanion shares are held by company insiders. Comparatively, 25.5% of Oscar Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Trupanion has a beta of 1.76, indicating that its stock price is 76% more volatile than the S&P 500. Comparatively, Oscar Health has a beta of 1.66, indicating that its stock price is 66% more volatile than the S&P 500.
In the previous week, Trupanion had 9 more articles in the media than Oscar Health. MarketBeat recorded 15 mentions for Trupanion and 6 mentions for Oscar Health. Trupanion's average media sentiment score of 0.65 beat Oscar Health's score of 0.60 indicating that Trupanion is being referred to more favorably in the media.
Trupanion currently has a consensus price target of $32.80, indicating a potential upside of 8.47%. Oscar Health has a consensus price target of $15.00, indicating a potential downside of 33.39%. Given Trupanion's higher possible upside, equities analysts plainly believe Trupanion is more favorable than Oscar Health.
Trupanion received 495 more outperform votes than Oscar Health when rated by MarketBeat users. Likewise, 66.41% of users gave Trupanion an outperform vote while only 53.70% of users gave Oscar Health an outperform vote.
Summary
Trupanion and Oscar Health tied by winning 9 of the 18 factors compared between the two stocks.
Get Trupanion News Delivered to You Automatically
Sign up to receive the latest news and ratings for TRUP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TRUP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Trupanion Competitors List
Related Companies and Tools
